BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24205430)

  • 1. Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.
    Mendes TA; Reis Cunha JL; de Almeida Lourdes R; Rodrigues Luiz GF; Lemos LD; dos Santos AR; da Câmara AC; Galvão LM; Bern C; Gilman RH; Fujiwara RT; Gazzinelli RT; Bartholomeu DC
    PLoS Negl Trop Dis; 2013; 7(10):e2524. PubMed ID: 24205430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.
    Reis-Cunha JL; Mendes TA; de Almeida Lourdes R; Ribeiro DR; Machado-de-Avila RA; de Oliveira Tavares M; Lemos DS; Câmara AC; Olórtegui CC; de Lana M; da Cunha Galvão LM; Fujiwara RT; Bartholomeu DC
    PLoS One; 2014; 9(9):e106304. PubMed ID: 25225853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.
    Alessio GD; de Araújo FF; Côrtes DF; Sales Júnior PA; Lima DC; Gomes MS; do Amaral LR; Xavier MA; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005444. PubMed ID: 28333926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas' disease.
    Elisei RMT; Matos CS; Carvalho AMRS; Chaves AT; Medeiros FAC; Barbosa R; Marcelino AP; Dos Santos Emidio K; Coelho EAF; Duarte MC; de Oliveira Mendes TA; da Costa Rocha MO; Menezes-Souza D
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):6069-6080. PubMed ID: 29736822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.
    Bottino CG; Gomes LP; Pereira JB; Coura JR; Provance DW; De-Simone SG
    BMC Infect Dis; 2013 Dec; 13():568. PubMed ID: 24299278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of peptide-based lineage-specific serology for chronic Chagas disease: geographical and clinical distribution of epitope recognition.
    Bhattacharyya T; Falconar AK; Luquetti AO; Costales JA; Grijalva MJ; Lewis MD; Messenger LA; Tran TT; Ramirez JD; Guhl F; Carrasco HJ; Diosque P; Garcia L; Litvinov SV; Miles MA
    PLoS Negl Trop Dis; 2014 May; 8(5):e2892. PubMed ID: 24852444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic, functional and serological aspects of genotypic-specific immune response of experimental T. cruzi infection.
    da Silveira-Lemos D; Alessio GD; Batista MA; de Azevedo PO; Reis-Cunha JL; Mendes TAO; Lourdes RA; de Lana M; Fujiwara RT; Filho OAM; Bartholomeu DC
    Acta Trop; 2021 Oct; 222():106021. PubMed ID: 34161815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accomplishing the genotype-specific serodiagnosis of single and dual Trypanosoma cruzi infections by flow cytometry Chagas-Flow ATE-IgG2a.
    Alessio GD; de Araújo FF; Sales Júnior PA; Gomes MS; Amaral LRD; Pascoal Xavier MA; Teixeira-Carvalho A; de Lana M; Martins-Filho OA
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006140. PubMed ID: 29462135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution profiling of linear B-cell epitopes from mucin-associated surface proteins (MASPs) of Trypanosoma cruzi during human infections.
    Durante IM; La Spina PE; Carmona SJ; Agüero F; Buscaglia CA
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005986. PubMed ID: 28961244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into Trypanosoma cruzi evolution, genotyping and molecular diagnostics from satellite DNA sequence analysis.
    Ramírez JC; Torres C; Curto MLA; Schijman AG
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006139. PubMed ID: 29253860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage-specific rapid diagnostic tests can resolve Trypanosoma cruzi TcII/V/VI ecological and epidemiological associations in the Argentine Chaco.
    Murphy N; Macchiaverna NP; Victoria Cardinal M; Bhattacharyya T; Mertens P; Zeippen N; Gustin Y; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2019 Sep; 12(1):424. PubMed ID: 31522683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.
    Santos FL; Celedon PA; Zanchin NI; de Souza WV; da Silva ED; Foti L; Krieger MA; Gomes YM
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005433. PubMed ID: 28273127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.
    Gironès N; Rodríguez CI; Carrasco-Marín E; Hernáez RF; de Rego JL; Fresno M
    J Clin Invest; 2001 Apr; 107(8):985-93. PubMed ID: 11306602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lineage-specific rapid diagnostic test (Chagas Sero K-SeT) identifies Brazilian Trypanosoma cruzi II/V/VI reservoir hosts among diverse mammalian orders.
    McClean MCW; Bhattacharyya T; Mertens P; Murphy N; Gilleman Q; Gustin Y; Zeippen N; Xavier SCC; Jansen AM; Miles MA
    PLoS One; 2020; 15(1):e0227828. PubMed ID: 31951634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
    Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
    Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.
    Zingales B
    Acta Trop; 2018 Aug; 184():38-52. PubMed ID: 28941731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR strategy for the identification of Trypanosoma cruzi discrete typing units directly in chronically infected human blood.
    Muñoz-San Martín C; Apt W; Zulantay I
    Infect Genet Evol; 2017 Apr; 49():300-308. PubMed ID: 28185987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple methodology to directly genotype Trypanosoma cruzi discrete typing units in single and mixed infections from human blood samples.
    Bontempi IA; Bizai ML; Ortiz S; Manattini S; Fabbro D; Solari A; Diez C
    Infect Genet Evol; 2016 Sep; 43():123-9. PubMed ID: 27208806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.
    Guzmán-Gómez D; López-Monteon A; de la Soledad Lagunes-Castro M; Álvarez-Martínez C; Hernández-Lutzon MJ; Dumonteil E; Ramos-Ligonio A
    Parasit Vectors; 2015 Sep; 8():466. PubMed ID: 26384317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.